Neutrogena Makeup Wipe Bacteria Contamination Lawsuit Lawyers

Pluralibacter Gergoviae Detected in Popular Cleansing Towelettes Distributed in Four U.S.

A well-known skincare product trusted by millions is now the subject of a national recall. Neutrogena’s Makeup Remover Ultra-Soft Cleansing Towelettes were voluntarily pulled from shelves following contamination with Pluralibacter gergoviae, a bacterium capable of causing infections. On September 19, 2025, the FDA confirmed that over 1,300 units of the affected product had been distributed in multiple U.S. states. While the recall is currently labeled as Class II, indicating a lower risk than more urgent Class I recalls, there remains a serious concern for those with compromised immune systems.

This recall affects people who use these wipes as part of their daily skincare routines. The bacteria can survive on skin, enter the body through broken tissue or mucous membranes, and lead to health complications ranging from urinary tract infections to sepsis in rare cases. Understanding the scope of this recall, the risks involved, and what actions are available for affected individuals is crucial, especially for consumers who may have suffered adverse reactions.

What the Recall Includes and Who Is Affected

The recall targets Neutrogena’s Makeup Remover Ultra-Soft Cleansing Towelettes, specifically the 2-pack of 25-count towelettes bearing Lot Code: 1835U6325A. This lot was distributed across Florida, Georgia, South Carolina, and Texas. Consumers are encouraged to check the back of the package to confirm the lot code. If the code matches the recalled batch, the product should be discarded immediately.

This product is typically marketed to individuals seeking quick and convenient facial cleansing without the need for water. Users include teenagers, adults with active lifestyles, and people with mobility challenges. While most users may not experience symptoms, those with underlying health conditions or suppressed immune systems are especially vulnerable.

This recall affects products already distributed. No announcement has confirmed whether the tainted wipes are still in stock at major retailers or online, which increases the risk that contaminated products may remain in homes, handbags, travel kits, or restrooms.

Understanding Pluralibacter gergoviae and Its Health Impact

Pluralibacter gergoviae is an environmental bacterium that has been previously linked to contamination in personal care products. It can survive and multiply in moist conditions, such as those found inside sealed wipe packages. While considered a moderate threat, the bacterium can pose serious dangers when it infects high-risk individuals.

Health complications reported in connection with this pathogen include:

• Urinary Tract Infections (UTIs)
• Respiratory Infections
• Eye Irritations or Infections
• Sepsis or bloodstream infections in rare but severe cases

The bacterium can enter the body through broken skin, the eyes, or mucous membranes. A seemingly minor irritation could evolve into a more serious medical issue, especially if untreated or misdiagnosed. For immunocompromised individuals—such as those undergoing chemotherapy, people living with HIV/AIDS, or transplant recipients—the risk of complications is far more significant.

FDA’s Classification of the Recall and What It Means

The FDA labeled this as a Class II recall, indicating that while the probability of serious health consequences is considered low, temporary or medically reversible adverse effects are possible. This includes skin irritations, minor infections, or temporary illnesses that do not result in long-term harm. However, the classification does not diminish the concerns of those who have already experienced symptoms or complications.

Previous Class II recalls involving Pluralibacter gergoviae include skincare products, baby wipes, and moisturizing lotions. In 2022, Jergens Ultra Healing Moisturizer was recalled for the same bacterial contamination. This repeat appearance raises additional questions about manufacturing oversight and whether preventative measures are being implemented industry-wide.

Geographic Scope and Risk of Further Exposure

According to the FDA, the contaminated Neutrogena wipes were distributed in:

• Florida
• Georgia
• South Carolina
• Texas

The total number of packages involved in the recall is 1,312. However, the lack of specific distributor information means consumers across the region may have unknowingly purchased the affected lot from pharmacies, grocery stores, or online platforms. Furthermore, secondary distribution—when one retailer sells to another business—makes full tracking more difficult.

With no publicized list of retailer locations, it’s possible that other areas beyond the four primary states may have received the recalled product. That means individuals outside the listed states should also examine their packaging for the listed lot code.

What Consumers Should Do If They Have the Product

Consumers who purchased the Neutrogena wipes are advised to check the back of the packaging for Lot Code 1835U6325A. If the code matches, the safest course of action is to stop using the product immediately and dispose of it in a sealed trash bag to prevent further exposure.

Although neither the FDA nor Neutrogena has issued detailed instructions about refunds or returns, most retailers will honor refunds for recalled products. Keep the packaging or a photograph of the lot code as evidence if seeking a return or submitting a complaint.

If symptoms arise following the use of these wipes, individuals should seek medical care and inform their doctor about the potential for bacterial exposure through contaminated cosmetics. This is especially critical for people with existing health conditions or who are taking medications that weaken their immune response.

Legal Implications and Consumer Rights

Manufacturers and distributors have a legal duty to ensure that personal care products are safe for consumer use. When a product causes harm due to contamination, victims may have a legal claim for compensation under several legal theories, including:

• Product Liability: Companies can be held responsible if their product was contaminated, improperly tested, or inadequately labeled.
• Negligence: Failure to follow manufacturing safety protocols or conduct adequate microbial testing.
• Failure to Warn: If the company did not take adequate steps to warn the public after learning of the risk.

Consumers who suffered harm—whether temporary illness, long-term complications, or out-of-pocket expenses for treatment—may be entitled to compensation. This can include medical bills, lost wages, emotional distress, and other damages.

How a Personal Injury Law Firm Can Help

Cases involving contaminated consumer products often require a thorough investigation. Medical records, product testing, and distribution documentation must be reviewed to build a strong case. A national personal injury law firm can assist by:

• Coordinating medical evaluations for affected consumers
• Submitting claims for economic and non-economic damages
• Handling negotiations with large corporate legal teams
• Filing product liability lawsuits in state or federal court if needed

For those injured by the recalled Neutrogena wipes, time limits to file a legal claim vary by state. Taking early action can make a significant difference in the strength and outcome of a case.

Neutrogena Makeup Wipe Recall Lawsuit FAQs

What product is being recalled?
Neutrogena Makeup Remover Ultra-Soft Cleansing Towelettes, specifically the 2-pack of 25-count wipes with Lot Code 1835U6325A.

Why were the wipes recalled?
The FDA detected Pluralibacter gergoviae, a bacterium known to cause infections in vulnerable individuals and, in rare cases, healthy people. This prompted a voluntary recall classified as Class II.

What health problems can the bacteria cause?
Potential complications include urinary tract infections, eye infections, skin irritations, respiratory infections, and in rare instances, sepsis.

How do I know if I have the recalled batch?
Check the back of the packaging for Lot Code 1835U6325A. If the code matches, discontinue use immediately.

What should I do if I used the wipes and feel sick?
Consult your doctor and mention the FDA recall and potential exposure to Pluralibacter gergoviae. Keep any unused wipes and receipts, if available.

Can I get a refund?
While Neutrogena has not confirmed a refund process, most retailers will offer a return or credit if presented with the product and proof of purchase.

Is legal action possible?
Yes. If the wipes caused illness or medical treatment was needed, you may have grounds for a product liability claim.

Do I need proof of purchase?
While not always necessary, it helps. Medical documentation and evidence of use, such as the product or packaging, can support your case.

Contact Parker Waichman LLP For A Free Case Review

If you or someone in your household suffered an infection, illness, or medical complications after using Neutrogena’s recalled cleansing towelettes, legal options may be available. Parker Waichman LLP is a national personal injury law firm currently investigating claims related to this recall.

Our legal team is committed to helping victims seek justice and financial recovery for medical expenses, lost income, and pain and suffering. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free consultation.